Skip to main content
Watch Insiders
FULCHealthcare

Fulcrum Therapeutics Inc (FULC) Insider Trading

In the last 90 days, no Fulcrum Therapeutics Inc (FULC) insiders reported open-market purchases or sales on SEC Form 4.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
0
90-day purchase value
$0.00
Corporate buyers
0
Latest transaction
Jul 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Jul 17, 2026Kevin Tang10% OwnerOpen Market Purchase167,616$3.55$594,668
Jul 17, 2026Tang Capital Management LLCCorporate insiderOpen Market Purchase167,616$3.55$594,668
Jul 15, 2026Kevin Tang10% OwnerOpen Market Purchase249,946$3.57$891,057
Jul 15, 2026Tang Capital Management LLCCorporate insiderOpen Market Purchase249,946$3.57$891,057
Jun 26, 2026Alan EzekowitzDirectorSale18,000$3.65$65,614

Common questions

FULC insider trading FAQ

Are FULC insiders buying or selling?
No FULC insiders reported open-market purchases or sales in the last 90 days.
When was the last FULC insider purchase?
No open-market insider purchase of Fulcrum Therapeutics Inc stock was reported in the last 90 days.
Where does FULC insider trading data come from?
Watch Insiders reads the SEC Form 4 filings that Fulcrum Therapeutics Inc officers, directors, and 10% owners submit to EDGAR, and refreshes this page daily.